You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 137 No. 12, December 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  This Month in Archives of Surgery
 This Article
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

This Month in Archives of Surgery

Arch Surg. 2002;137:1330.

Dr Arthur E. Baue, a former editor of the ARCHIVES and a former Chairman of Surgery at a prestigious medical school, reiterates the feelings of others that there are too many societies, too many meetings, and too many publications of insignificant merit or incompleteness.

As long as personalities, egos, the publish-or-perish mentality, affluence, and money from commercial sources and publishing houses tempt us, restraint is difficult, if not impossible. The only solution appears to be that offered by Hom, Organ, and Twomey (Am Coll Surgeons Bull. 1991;76:23-26), that of merging organizations and publications. Dr Baue concludes with the Harvard Law of Experimentation: "Under controlled conditions, animals and people (and organizations and publishers) behave as they damn well please."

(SEE ARTICLE)

Another report by an author who is very knowledgeable in his field relates to bacterial resistance to antibiotics. Dr Robert E. Condon, a longtime leader in this area and a thoughtful person, looks at the practical aspects of dealing with this problem and makes some important suggestions. He notes that "Bacterial resistance to antimicrobials will always be a problem" and that we now need to "choose novel strategies that have a potential for success."

(SEE ARTICLE)

Schwartz and Tumblin present a review of competitive health care organizations and point out the domination by leaders who practice an outmoded transactional style of leadership that breeds mediocrity and stagnation. They contrast this with entrepreneurship outside the health care sector, emphasizing the characteristics of successful leadership. Their report is well worth reading and pondering.

(SEE ARTICLE)

A Comparison of Percutaneous Cryosurgery and Percutaneous Radiofrequency for Unresectable Hepatic Malignancies

Because a large percentage of patients with hepatic malignancy have contraindications to major resection, this article by Adam et al, a highly experienced liver group from Villejuif, France, continues the search for the best ways to manage this difficult group of patients. Owing to the small number of patients involved, it is difficult to make a definitive statement, but it does appear that percutaneous radiofrequency ablation has an advantage in recurrence rate over percutaneous cryosurgery in patients with metastatic but not primary liver cancer.

(SEE ARTICLE)


Hand-Assisted Laparoscopic Splenectomy vs Conventional Laparoscopic Splenectomy in Cases of Splenomegaly

In this era of laparoscopic, minimally invasive surgery, elective splenectomy is rarely performed by open technique. However, as Rosen, Ponsky, et al from the Cleveland Clinic, Cleveland, Ohio, report, splenomegaly may preclude safe mobilization and hilar control using a conventional laparoscopic procedure. In a modest series, hand-assisted laparoscopic splenectomy was employed with success for those patients with significantly larger spleens; there was no mortality.



(SEE ARTICLE)


The Use of Molecular Profiling of Early Colorectal Cancer to Predict Micrometastases

As a logical extension of the sentinel node mapping technique, Bilchik et al have used molecular profiling in patients with early colorectal cancer. Of 31 patients with negative nodes on hematoxylin-eosin staining, 8 (26%) showed occult micrometastases by immunohistochemical staining, which correlated with the increased presence of tumor markers in the primary lesion.

(SEE ARTICLE)







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.